Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease by United Pompe | Jan 18, 2016 | News | 0 comments Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease Submit a Comment Cancel replyYou must be logged in to post a comment.
